Praxis Precision Medicines (PRAX) had the highest return between January 7, 2024 and January 14, 2024 by a small-cap US stock, returning 66%.
ASSET | DATE | % RETURN |
---|---|---|
Praxis Precision Medicines (PRAX) | 1/7/2024 - 1/14/2024 | 66.04% |
Nkarta (NKTX) | 1/7/2024 - 1/14/2024 | 48.75% |
Clene (CLNNW) | 1/7/2024 - 1/14/2024 | 46.68% |
Amarin (AMRN) | 1/7/2024 - 1/14/2024 | 39.28% |
Ardelyx (ARDX) | 1/7/2024 - 1/14/2024 | 38.92% |
Plum Acquisition Corp I (PLMIW) | 1/7/2024 - 1/14/2024 | 37.93% |
Kernel (KRNLW) | 1/7/2024 - 1/14/2024 | 36.36% |
NewAmsterdam Pharma (NAMS) | 1/7/2024 - 1/14/2024 | 35.37% |
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 1/7/2024 - 1/14/2024 | 34.48% |
Y mAbs Therapeutics (YMAB) | 1/7/2024 - 1/14/2024 | 34.4% |
Establishment Labs (ESTA) | 1/7/2024 - 1/14/2024 | 32.76% |
Cartesian Therapeutics (RNAC) | 1/7/2024 - 1/14/2024 | 30.77% |
immatics biotechnologies GmbH (IMTXW) | 1/7/2024 - 1/14/2024 | 30.29% |
GeneDx (WGS) | 1/7/2024 - 1/14/2024 | 29.79% |
Sana Biotechnology (SANA) | 1/7/2024 - 1/14/2024 | 29.08% |
Net Lease Office Properties (NLOP) | 1/7/2024 - 1/14/2024 | 28.23% |
Acm Research (ACMR) | 1/7/2024 - 1/14/2024 | 27.54% |
Neurogene (NGNE) | 1/7/2024 - 1/14/2024 | 27.48% |
Transphorm Technology (TGAN) | 1/7/2024 - 1/14/2024 | 27.32% |
Quantum-Si (QSIAW) | 1/7/2024 - 1/14/2024 | 26.14% |
Real Brokerage (REAX) | 1/7/2024 - 1/14/2024 | 25.99% |
Accolade (ACCD) | 1/7/2024 - 1/14/2024 | 25.61% |
Sage Therapeutic (SAGE) | 1/7/2024 - 1/14/2024 | 25.06% |
Uranium Royalty (UROY) | 1/7/2024 - 1/14/2024 | 24.9% |
Solid Biosciences LLC (SLDB) | 1/7/2024 - 1/14/2024 | 24.76% |